Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07145489
Recruiting
Infrared Photobiomodulation in Humans With Epilepsy
Not applicable · United States · 1 site
Registry update: 4 Feb 2026
NCT07181317
Recruiting
WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up
Not applicable · France · 1 site
Registry update: 12 Jan 2026
NCT07270731
Recruiting
A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
Phase 1 · Germany · 1 site
Registry update: 20 Jul 2026
NCT07195149
Recruiting
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
Phase 3 · Poland · 18 sites
Registry update: 27 Oct 2026
NCT07272239
Recruiting
Effects of tVNS and mCIMT in Chronic Stroke
Not applicable · Pakistan · 2 sites
Registry update: 9 Dec 2025
NCT07173855
Recruiting
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
Phase 4 · Canada · 6 sites
Registry update: 24 Sept 2026
NCT07187531
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Austria, Australia, Belgium, Germany, Denmark, Spain, Finland, France, United Kingdom, Italy, Lithuania, New Zealand, Poland, Slovenia, United States · 68 sites
Registry update: 13 Oct 2026
NCT07161414
Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
Phase 1 · Spain, United Kingdom, South Korea, United States · 8 sites
Registry update: 5 Oct 2026
NCT07040189
Recruiting
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
Not applicable · Germany · 3 sites
Registry update: 21 Aug 2026
NCT07742332
Recruiting
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
Phase 2 · China · 1 site
Registry update: 3 Aug 2026
NCT07164911
Recruiting
Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction
Not applicable · France · 1 site
Registry update: 16 Dec 2025
NCT07537660
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
Phase 2 · China · 1 site
Registry update: 17 Apr 2026
NCT07109154
Recruiting
DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
Not applicable · Brazil · 4 sites
Registry update: 13 May 2026
NCT07270666
Recruiting
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Not applicable · United States · 7 sites
Registry update: 25 Sept 2026
NCT06931509
Recruiting
Integration and Interactions Between Visual and Proprioceptive Feedbacks
Not applicable · France · 1 site
Registry update: 24 Jul 2026
2024-519590-19-00
Recruiting
A study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo®, in combination with mFOLFOX6 and bevacizumab versus standard of care in participants with non MSI-H/dMMR, PD-L1 positive advanced colorectal cancer.
Phase 2 · Spain, France, Italy · 21 sites
Registry update: 9 Sept 2026
NCT06902077
Recruiting
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Not applicable · United States · 1 site
Registry update: 8 Dec 2025
NCT07381491
Recruiting
Effects of Core Strengthening With Pelvic Proprioceptive Neuromuscular Facilitation on Trunk Control and Balance in Patients With Sub-acute Stroke
Not applicable · Pakistan · 1 site
Registry update: 2 Feb 2026
NCT07223047
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Phase 1/2 · Canada, Spain, United States · 8 sites
Registry update: 28 May 2026
NCT07226219
Recruiting
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Phase 1 · United States · 1 site
Registry update: 9 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.